Bain Capital to buy PCI Pharma at $10 billion valuation, Bloomberg News reports
Bain Capital is in talks to buy contract drug manufacturer PCI Pharma Services at a valuation of $10 billion, Bloomberg News reported on Friday, citing people familiar with the matter.
More info
